OPK
USDOPKO Health Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.370
High
$1.430
Low
$1.370
Volume
2.69M
Company Fundamentals
Market Cap
1.1B
Industry
Diagnostics & Research
Country
United States
Trading Stats
Avg Volume
2.21M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6
Jefferies analyst Maury Raycroft downgrades OPKO Health from Buy to Hold and lowers the price target from $2 to $1.6.
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
Barrington Research analyst Michael Petusky maintains OPKO Health with a Outperform and maintains $2.25 price target.
OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28,
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial
Related Stocks
BYRN
Byrna Technologies Inc.
ARLP
Alliance Resource Partners L.P. Common Units representing Limited Partners Interests
ADBE
Adobe Inc.
IRON
Disc Medicine Inc.
SABA
Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.